WAT SON 406
Pill imprint WAT SON 406 has been identified as Lisinopril 5 mg.
Lisinopril is used in the treatment of high blood pressure; heart failure; heart attack; diabetic kidney disease; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Lisinopril 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Lisinopril Images
- Imprint:
-
WAT SON
406 - Strength:
- 5 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
pregelatinized starch
corn starch
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0406
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0348 | McKesson Packaging Services |
Note: Inactive ingredients may vary.
Advertisement
More Lisinopril resources
- Lisinopril
- Lisinopril (Wolters Kluwer)
- lisinopril (Cerner Multum)
- lisinopril (Micromedex) - Includes Dosage Information
- Lisinopril (AHFS DI)
- Lisinopril (FDA)
- Lisinopril (Wolters Kluwer)
Search Again
